Medtronic Tells Board Patented Ablation Probe Would Have Been Obvious
ALEXANDRIA, Va. — In a May 29 petition for inter partes review (IPR), Medtronic Inc. argues that the Patent Trial and Appeal Board should cancel claims 1-8, 13 and 17-22 of...To view the full article, register now.
Already a subscriber? Click here to view full article